VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve 1. Un-Audited financial results for the quarter ended 31.12.2023\r\n2. Limited Review Report for quarter ended 31.12.2023\r\n3. Any other business with the permission of the Chair.\r\n